Allogene Therapeutics grabs funding from Vida Ventures
South San Francisco-based Allogene Therapeutics, a biotech company focused on cancer treatment, has secured an undisclosed amount of funding. The investor was Vida Ventures.
3 April 2018•2 mins read
